AST
AST2-A  Point-of-Care in Vitro Diagnostic (IVD) Testing (1999.6)
AST3-A  Wellness Testing Using IVD Devices (1999.2)
AST4-A  Blood Glucose Testing in Settings Without Laboratory Support (1999.6)

C
C3-A3    Preparation and Testing of Reagent Water in the Clinical Laboratory (1997.10)
C24-A2   Statistical Quality Control for Quantitative Measurements: Principle and Definitions 
(1999.2)
C28-A2   How to Define and Determine Reference Intervals in the Clinical Laboratory (2000.6)
C29-A2   Standardization of Sodium and Potassium Ion-Selective Electrode Systems to the 
Flame Photometric Reference Method (2000.10)
C30-A2   Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities (2002.8)
C31-A2*  Ionized Calcium Determinations: Precollection Variables, Specimen Choice, 
Collection, and Handling (2001.6)
C34-A2   Sweat Testing: Sample Collection and Quantitative Analysis (2000.6)
C37-A    Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary
 Reference Materials for Cholesterol Measurement Procedures  (1999.11)
C38-A    Control of Preparation Variation in Trace Element Determinations (1997.9)
C39-A    A Designated Comparison Method for the Measurement of Ionized Calcium in Serum 
(2000.4)
C40-A    Analytical Procedures for the Determination of Lead in Blood and Urine (2001.6)
C42-A    Erythrocyte Protoporphyrin Testing (1996.11)
C43-A    Gas Chromatography/mass Spectrometry (GC/MS) Confirmation of Drugs (2002.11)
C44-A    Harmonization of Glycohemoglobin Measurements (2002.12)
C46-A    Blood Gas and pH Analysis and Related Measurememnts (2001.9)

DI
DI2-A2   Immunoprecipitin Analyses: Procedures for Evaluating the Performance of Materials. 
(1993.10)
DI3-A    Agglutination Assayses: Antibody Characteristics,Methodology, Limitations,and 
Clinical Validation (1993.10)

EP
EP5-A2    Evaluation of Precision Performance of Quantative measurement methods; 
Approved Guideline-Second Edition (2004.08)
EP6-A    Evaluation of the Linearity of Quantative Analytical Methods (2003.4)
EP7-A    Interference Testing in Clinical Chemistry (2002.12)
EP9-A2   Method Comparison and Bias Estimation Using Patient Samples (2002.9)
EP10-A2  Preliminary Evaluation of Quantitative Clinical Laboratory Methods (2002.12)
EP12-A   User Protocol for Evaluation of Qualitative Test Performance (2002.8)
EP13-R   Laboratory Statistics-Standard Deviation.(1995.8)
EP14-A*  Evaluation of Matrix Effects (2001.3)
EP15-A*  User Demonstration of Performance for Precision and Accuracy (2001.12)
EP18-A   Quality Management for Unit-Use Testing (2002.12)
EP19-R   A Framework for NCCLS Evaluation Protocols. (2002.6)
EP21-A   Estimation of Total Analytical Error for Clinical Laboratory Methods (2003.4)

G
GP2-A4*  Clinical Laboratory Technical Procedure Manuals (2002.4)
GP5-A2   Clinical Laboratory Waste Management (2002.4)
GP6-A    Inventory Control Systems for Laboratory Supplies.(1994.2)
GP9-A    Selecting and Evaluating a Referral Laboratory (1998.11)
GP10-A   Assessment of the Clinical accuracy of Laboratory Tests Using Receiver Operating 
Characteristics (ROC) Plots (1995.12)
GP11-A   Basic Cost Accounting in the Clinical Services (1998.11)
GP14-A   Labeling of Home-Use In Vitro Testing products.(1996.6)
GP15-A2*  Papanicolaou Technique (2001.11)
GP16-A2*  Urinalysis and Collection, Transportation, and Preservation of Urine Specimens
          (2001.11)
GP17-A   Clinical Laboratory Safety.(1996.12)
GP18-A   Laboratory Design (1998.4)
GP19-A2  Laboratory Instruments and Data Management Systems: Design of Software User 
Interface and End-User Software Systems Validation, Operation, and Monitoring 
(2003.2)
GP20-A2  Fine Needle Aspiration Biopsy (FNAB) Techniques (2003.10)
GP21-A   Traning Verification for Laboratory Personnel.(1995.12)
GP22-A   Continuous Quality Improvement: Essential Management Approaches (1999.8)
GP23-A   Nongynecologic Cytologic Specimens: Collection and Cytopreparatory Techniques 
(1999.8)
GP26-A2  Application of a Quality System Model to Laboratory Services (2003.2)
GP27-A   Using Proficiency Testing (PT) to Improve the Clinical Laboratory (1999.8)
GP29-A   Validation of Laboratory Tests When Proficiency Testing is Not Available (2002.12)

H
H1-A5    Evacuated Tubes and Additives for Blood Specimen Collection—4th Edition (2003.12)
H2-A4    Reference and selected procedure for the Erythrocyte Sedimentation Rate(ESR) Test 
(2000.12)
H3-A5    Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture 
(2003.12) 
H4- A4    Procedures and Devices for the Collection of Diagnostic Blood Specimen by Skin 
Puncture (1999.9)
H7-A3    Procedure for Determining Packed Cell Volume by the Microhematocrit Method
(2000.12)
H11-A3   Procedures for the Collection of Arterial Blood Specimens (1999.5)
H15-A3   Reference and Selected Procedures for the quantitative Determination of Hemoglobin 
in Blood (2000.12)
H17-A    Determination of Serum Iron, Total Iron-Binding Capacity6 and Percent Transferrin 
Saturation (1998.12)
H18-A2   Procedures for the Handling and Processing of Blood Specimens (1999.10)
H20-A    Reference Leukocyte Differential Count (Proportional) and Evaluation of Instrumental 
Methods (1992.3)
H21-A4   Collection, Tranport, and Processing of Blood Specimens for Coagulation testing and 
General performance of Coagulation Assays (2003.12)
H26-A    Performance Goals for the Internal Quality Control of Multichannel Hemotology 
Analyzers (1996.12)
H30-A2*  Procedure for the Determination of Fibrinogen in Plasma (2001.12)
H42-A    Clinical Applications of Flow Cytometry: Quality Assurance and Immunophenotyping 
of Lymphocytes (1998.12)
H43-A    Clinical Applications of Flow Cytometry: Immunophenotyping of Leukemic Cells 
(1998.6)
H44-A    Methods for Reticulocyte Counting( Flow Cytometry, and Supravital Dyes) (1997.10)
H45-A    Performance of the Bleeding Time Test (1998.6)
H47-A    One-Stage prothrombin Time (PT) Test and Activated Partial Thromboplastin Time 
(APTT) Test. (1996.6)
H51-A    Assays of von Willebrend Factor Antigen and Ristocetin Cofactor Activity (2002.9)
H52-A*   Fetal Red Cell Detection (2001.12)

HS
HS1-A    A Quality System Model for Health Care (2002.8)
HS2-A    Provider-Performed Microscopy Testing (2003.2)
HS4-A    Application of a Quality System Model to Respiratory Services (2002.11)
HS5-A    Application of a Quality System Model for Medical Imaging Services (2002.11)

I/LA
I/LA-2A   Quality Assurance for the Indirect Immunofluorescence Test for Autoantibodies to 
Nuclear Antigen(IF-ANA);(1996.12)
I/LA6-A   Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance 
Criteria for muleiple Component Test Product and Specimen Handling and Use of 
Test Products in the Clinical Laboratory (1997.10)
I/LA10-A  Choriogonadotropin Testing:Nomenclature,Reference Preparations,Assay 
Performance,and Clinical Application (1996.12)
I/LA15-P  Apolipoprotein Immunoassays: Development and Recommended Performance 
Characteristics (1997.9)
I/LA17-A  Assessing the Quality of Systems for Alpha-Fetoprotein (AFP) Assays Used
in Prenatal Screening and Diagnosis of Open neural Tube Defects (1997.4)
I/LA18-A2* Specifications for Immunological Testiong for Infectious Diseases (2001.9)
I/LA19-A  Primary Reference Preparations Used to Standardize Calibration of Immunochemical 
Assays for serum Prostate specific antigen (PSA) (1997.6)
I/LA20-A  Evaluation Methods and Analytical Performance Characteristics of Immunological 
Assays for Human Immunoglobulin E (Ig E) Antibodies of Defined Allegen 
Specificities (1997.12)
I/LA21-A* Clinical Evaluation of Immunoassays (2002.6)

LA
LA1-A2   Assessing the Quality of Radioimmunoassay System（1994.12）
LA4-A4   Blood Collection on Filter Paper for Neonatal Screening Programs (2003.7)

M
M2-A8    Performance Standards for Antimicrobial Disk Susceptibility Tests (2003.1)
M6-A     Protocols for Evaluating Dehydrated Muller-Hinton Agar (1996.12)
M7-A6    Methods for Dilution Antimicrobial Suswceptibility Tests for Bacteria That Grow 
Aerobically (2003.1)
M11-A6   Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria (2004.1)
M15-A    Laboratory Diagnosis of Blood-Borne Parasitic Diseases (2000.6)
M21-A    Methodology for the Serum Bactericidal Test (1999.9)
M22-A2   Quality Assurance for Commercially Prepared Microbiological Culture 
Media-Second (1996.12)
M23-A2*  Development of In Vitro Susceptibility Testing Criteria and Quality Control 
Parameters (2001.5)
M24-A    Susceptibility Testing of Mycobacteria,Nocariae,and Other Aerobic Actinomycetes 
(2003.4)
M26-A    Methods for Determining Bactericidal Activity of Antimicrobial Agents (1999.9)
M27-A2   Reference Method for Broth Diloution Antifungal Susceptibility Testing of Yeasts 
(2002.8)
M28-A    Procedures for the Recovery and Identification of Parasites from the Intestinal 
Tract (1997.12)
M29-A2*  Protection of Laboratory Workers from Occupationally Acquired Infections (2001.12)
M100-S14* Performance Standards for Antimicrobial susceptibility Testing (2004.1)